Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5445_Библиотеки_им_академика_М_И_Перельмана.pdf
X
- •Contents
- •Editors and Contributors
- •About the Editors
- •Contributors
- •Abstract
- •1.1 Introduction
- •1.1.1 Historical Background
- •1.3.2 Pulmonary Drug Delivery
- •1.3.3 Parenteral Drug Delivery
- •1.4 Inulin Health Benefits
- •1.4.1 Prebiotic Effects
- •1.5 Inulin Industrial Applications
- •1.5.2 Pharmaceutical Uses
- •1.6.2 Regulatory Status Worldwide
- •1.7.1 Emerging Health Benefits
- •1.8 Conclusion
- •References
- •1.3 Inulin Drug Delivery Routes
- •1.3.1 Oral Drug Delivery
- •Abstract
- •2.1 Introduction
- •2.4 Physicochemical Characteristics
- •2.4.1 Chain Length
- •2.4.2 Solubility
- •2.4.3 Viscosity
- •2.4.4 Melting Temperature
- •2.4.5 Gelling
- •2.5.1 Extraction Through Hot Water
- •2.5.2 Extraction Using Ultrasound
- •2.5.3 Extraction Directed Through Microwave
- •2.7.1 Therapeutic Benefits
- •2.7.1.2 As Laxative
- •2.7.1.3 In Lipid Metabolism
- •2.7.1.5 Absorption Enhancer
- •2.8 Pharmaceutical Benefits
- •2.8.3 In PEGylation
- •2.8.5 As Gel
- •2.9 Diagnostic Benefits
- •2.10.2 Yield Variability
- •2.10.3 Purity Challenges
- •2.11 Future Scope
- •2.12 Conclusion
- •References
- •Abstract
- •3.1 Introduction
- •3.2 Inulin-Based Drug Formulations
- •3.3.1 Inulin-Based Hydrogels
- •3.3.2 Inulin-Based Micelles
- •3.3.3 Inulin-Based Liposomes
- •3.3.4 Inulin-Based Prodrugs
- •3.3.5 Inulin-Based Chelating Agents
- •3.3.6 Inulin-Based Microparticles
- •3.3.7 Inulin-Based Nanoparticles
- •3.6 Conclusions
- •References
- •Abstract
- •4.1 Introduction
- •4.3.1 Emulsifying Properties
- •4.3.3 Particle Stabilization
- •4.5.1 Solid Dosage Forms
- •4.5.3 Parenteral Formulations
- •4.5.4 Drug Delivery Systems
- •4.6.1 Skin Care Products
- •4.6.2 Hair Care Products
- •4.6.3 Personal Hygiene Products
- •4.7.2 Blood Sugar Regulation
- •4.9 Conclusion
- •References
- •Abstract
- •5.1 Introduction
- •5.5 Inulin-Based Drug Delivery Systems
- •5.5.1 Inulin Film Coating Agents
- •5.5.2 Biodegradable Inulin Coatings
- •5.5.3 Multipulse Delivery
- •5.5.4 Functional Inulin Coating Materials
- •5.5.5 Inulin Enteric Coatings/Colon Targeting
- •5.5.6 Tumor Targeting
- •5.5.7 Inulin Sustained Release Coatings
- •5.5.8 Hybrid Inulin-Based Coating Materials
- •5.5.9 Inulin Taste-Masking Coatings
- •5.5.10 Nanotechnology Using Inulin
- •5.7.1 Agriculture
- •5.7.2 Diagnosis
- •5.7.3 MRI Diagnosis
- •5.7.4 Medicine
- •5.7.5 Bioremediation
- •References
- •Abstract
- •Abbreviations
- •6.1 Introduction
- •6.1.1 Background
- •6.2 Understanding Prebiotics
- •6.4.2 Fermentation by Gut Microbiota
- •6.6.1 Bidirectional Communication
- •6.8 Future Perspective
- •6.9 Conclusion
- •References
- •7.2.2 Anti-Inflammatory Effects
- •7.3.1 Skin Whiteners
- •7.3.2 Hair Care
- •7.4 Regulatory Status
- •7.5 Conclusion
- •References
- •Abstract
- •7.1 Introduction
- •Abstract
- •8.1 Introduction
- •8.2.3 Anatomical Characteristics
- •8.2.4 Thermodynamic Stability
- •8.4.2 Formulation Strategies
- •8.5.3 Regulatory Considerations
- •8.9 Regulatory Considerations
- •8.11 Conclusion
- •References
- •Abstract
- •9.1 Introduction
- •9.2 Inulin-Based Pharmaceutical Applications
- •9.3.1.1 GIT
- •9.3.1.2 CNS
- •9.3.1.3 CVS
- •9.3.1.4 Hypersensitivity Reactions
- •9.3.1.5 Other Reported Adverse Effects
- •9.3.2 Inulin Interactions
- •9.4.1 Acceptable Daily Intake
- •9.4.3.2 Adults
- •9.4.3.3 Elderly Individuals
- •9.4.3.4 Pregnant or Lactating Women
- •9.5.1 Clinical Trial Outcome
- •9.5.2 Animal Studies
- •9.5.3 In Vitro Studies
- •9.6 Future Prospects
- •9.7 Conclusion
- •References
- •Abstract
- •Abbreviations
- •10.1 Introduction
- •10.2.2.1 Prebiotic Activity
- •10.2.2.2 Improved Gut Health
- •10.2.2.3 Anti-Inflammatory Effects
- •10.2.2.5 Enhanced Mineral Absorption
- •10.6.1 Potential Side Effects
- •10.6.2 Dosage Recommendations
- •10.7 Future Perspective
- •10.8 Conclusion
- •References
- •Abstract
- •11.19.1 Tolerance
- •11.20 Conclusion
- •References
- •Abstract
- •12.1 Introduction
- •12.5.1 Hydrogels
- •12.5.2 Microparticles
- •12.5.3 Nanoparticles
- •12.5.4 Inulin Conjugates
- •12.5.5 Miscellaneous
- •12.7 Conclusion
- •References
- •Abstract
- •13.5.1 Pharmaceutical Quality Assurance Framework
- •References
- •Abstract
- •14.1 Introduction
- •14.2.1 Prebiotic Nature
- •14.8 Immune-Modulatory Effects
- •14.9.3 Addressing Bone-Related Disorders
- •14.12 Cognitive Implications
- •14.13 Future Directions
- •14.14 Conclusion
- •References
- •Abstract
- •15.1 Introduction
- •15.3 Extraction Techniques
- •15.7.1 In Pharmaceutical Sector
- •15.7.1.4 As Vaccine Adjuvant
- •15.7.2 In Food Sector
- •References
- •Abstract
- •16.1 Introduction
- •16.1.3 Innovative Drug Delivery Systems
- •16.2 Functional Properties
- •16.2.1 Liquidity
- •16.2.2 Prebiotic Characteristics
- •16.2.3 Low Energy Density
- •16.2.5 Potential Health Benefits
- •16.3.3 Mucosal Delivery Systems
- •16.3.4 Liposomes
- •16.5 Future Perspectives
- •References

247
treatments centered on inexpensive ber supplementation. This may be accom-
plished by using various soluble and insoluble bers derived from cereals and veg-
etables. Diets high in ber may help healthy individuals become more peripherally
insulin-sensitive. Furthermore, soluble ber has the ability to postpone the blood’s
absorption of glucose, which lowers postprandial glucose concentrations (Bari
2010; Beirão-da-costa et al. 2005). Inulin, which falls under the broad group of
fructans, has a great deal of promise as soluble dietary ber to reduce these health
issues. Therefore, using inulin, one of the potential bioactive molecules with a wide
range of dietary uses, might be one way to make therapeutic foods (Blecker
etal. 2002).
11.18.2 Extraction andPrecipitation ofInulin
The extraction, measurement, and application of inulin are gaining attention because
to its increasing industrial usage in nature. To increase the yield of inulin, several
studies have examined the ideal extraction parameters, such as temperature, extrac-
tion duration, and solvent/solid ratios (Bonnema et al. 2010b). Upgrading the
extraction temperature signicantly increases the solubility of inulin, which is
essentially insoluble at 25°C but becomes soluble up to 35% at 90°C.Accordingly,
the majority of industrial extraction uses a hot water diffusion technique (Brkljača
etal. 2014).
The basis for almost all extraction techniques is the use of hot water diffusion
with very little variation in temperature and extraction duration. To increase extrac-
tion efciency, the hot water diffusion technique can also include continuous stir-
ring (Vervoort etal. 1999; Wada etal. 2005). In order to prevent inulin hydrolysis,
which is a common occurrence at pH<6, inulin is often extracted from JA using
distilled water at 80–85°C for 1h and pH6.8 as this was seen during the extraction
of inulin from burdock roots; many factors, including temperature, sonication
amplitude, and duration, have recently been proposed to increase extraction by
ultrasound assistance (Wang and Gibson 1993). Without signicantly changing the
temperature, the extraction efciency was increased by increasing the sonication
amplitude and extraction duration. The sonication duration was 25min, with an
amplitude of 83.22% and a temperature of 36.76°C.Because of the direct impact of
ultrasounds, care must be given during extraction to prevent inulin fragmentation. In
summary, employing direct waves is the recommended method for inulin depoly-
merization in order to get low molecular weight byproducts. To get intact inulin,
however, the indirect technique is more suited (Weir etal. 2018; Wolff etal. 2000).
11.18.3 Functional Health Attributes ofInulin asDietary Fiber
Dietary ber is made up of lignin, oligosaccharides, polysaccharides, and related
plant materials that may perform physiological actions in the human body, such as
reducing blood glucose or cholesterol levels and promoting bowel movements. For
11 Inulin andGastrointestinal Disorders

248
those following a healthy diet plan, 30g of dietary ber is advised for those using
2500kcal per day and 25g for those using 2000kcal (Yang etal. 2001). The World
Health Organization suggests 16–24g of non-starch polysaccharides and 27–40g
of total dietary ber per day. Water-soluble gel and water-insoluble bers are two
categories for dietary bers (Yoneda etal. 1848).
While soluble ber is found in no cellulosic portions such as mucilage, gums, and
pectin in legumes, barley, oats, fruits, and dried beans, insoluble ber is found in the
cell walls of grains and certain vegetables in the form of hemicelluloses and cellu-
lose. Soluble bers are associated with lipid and carbohydrate metabolism, but insol-
uble bers have minimal effect on the body’s ability to metabolize glucose and
cholesterol (Yu and Hu 2016; Zhang etal. 2005). By means of the underlying intes-
tinal fermentation, soluble ber may also produce the short-chain fatty acids (acetate,
propionate, and butyrate), which are essential for lipogenesis and lipogenolysis.
11.18.4 Relationship ofInulin andBowel Habits
Due to their agreement with the majority of the dietary ber criteria, inulin and
oligofructose are classied as dietary bers worldwide (Zhang etal. 2013, 2016).
They not only enhance bowel function but also have the capacity to ferment in the
colon and specically promote the establishment of advantageous intestinal bacte-
ria. The fermentation can increase the bacterial population; the resulting microora
can contribute signicantly to fecal biomass and water content of stool, leading to
bowel peristalsis, facilitated excretion, and increased frequency and output of stool
(Zhang etal. 2018). Regular consumption of inulin-type fructan can enhance intes-
tinal health and relieve constipation because it regulates bowel function. Constipation
often lasts into old age and can be caused by dietary patterns changing, drinking
more liquids, eating a lower-ber diet less frequently, taking too many laxatives and
medications, having a smaller intestine, and not exercising. Stool weight and intes-
tinal motility increased in research involving healthy human volunteers fed a diet
high in inulin (Sealy and Chalkley 1978; Shang etal. 2018).
11.18.5 Nutritional Benefits ofInulin
The development and multiplication of advantageous intestinal microora as well
as the activation of the systemic response through the synthesis of SCFAs and sev-
eral other unknown metabolites are credited with the positive effects of inulin-type
fructans (Shivhare etal. 2018). Additionally, they have a favorable impact on the
end products of fermentation and native bacterial enzymes. Several pieces of evi-
dence point to the benecial function of bacteria called biodobacteria in the body,
which increases resistance to infections (Sun et al. 2011, 2018). In addition to
boosting the quantity and rates of development of biodobacteria, inulin and oligo-
fructose can prevent the growth of dangerous pathogens like E. coli, Campylobacter
jejuni, Salmonella enteritidis, or Clostridium perfringens.
S. K. Kadiri et al.

249
According to human study ndings, the gut-associated lymphoid tissues are pos-
itively impacted by fructans, such as inulin and fructo-oligosaccharides, which in
turn helps to strengthen immunity against dangerous microorganisms (Taper and
Roberfroid 1999).
The fundamental consequences are associated with enhanced gastrointestinal
tract repair following disruptions, reduced symptoms of illness, and resistance to
pathogen translocation and colonization. The primary function of inulin-type fruc-
tans is to alleviate intestinal diseases in the population, including hospitalized
patients with diarrhea (diarrhea associated with Clostridium difcile). There have
been documented benets from raising bidal numbers and lowering diarrheal
relapses. Apart from its bidogenic properties, inulin has the ability to decrease the
inammation linked to ulcerative colitis. Fermentable bers were combined with
medications in a double-blind, placebo-controlled experiment to treat colon cancer
patients, with encouraging results. Fermentable bers, such as fructans of the inulin
type, can also improve the absorption of minerals (Terova etal. 2016).
11.19 Inulin: Safety andTolerance
Two macronutrients are oligofructose and inulin. They are utilized as food additives
or as a stand-in for macronutrients. They are mostly added to meals as supplements
because of their nutritional value. The amount of dietary ber in a food is increased
by adding oligofructose or inulin. These increases typically range from 3 to 6g per
serving and, in severe circumstances, up to 10g (Toneli etal. 2008; Tonnis etal.
2015). In other cases, oligofructose or inulin is added to support a particular nutri-
tional claim, such as the one about bidogenic action. Typical values in these meals
range from 1 to 6%, resulting in 3 to 8g per piece.
Inulin and oligofructose are primarily employed as macronutrient replacements
in place of fat and sugar, respectively. Orafti developed and patented the ability of
inulin to replace fat in food in 1992. Inulin is mixed with water using a particular
processing method to mimic the mouthfeel and texture of fat. Only meals that
include water, like dairy and spreads for tables, may do this; dry foods, including
most snacks, baked goods, and confections, cannot. Generally, 0.25g of inulin is
used in place of 1g of fat. As a result, most meals that substitute fat will have inulin
quantities of 2–4g per piece. Orafti developed and patented the ability of inulin to
replace fat in food in 1992 (Tripodo etal. 2015). While oligopolysaccharides have
technical characteristics with sugar and glucose syrups, they differ greatly in terms
of their nutritional makeup. When compared to sugar, the sweetness of (pure) oligo-
fructose is 30%. Because of this, it is challenging to utilize oligofructose alone as a
sugar substitute; in order to get the appropriate sweetness level, it is typically cou-
pled with strong sweeteners. Safety of the inulinase enzyme: Partial enzymatic
hydrolysis of inulin yields oligofructose. An inulinase enzyme that was separated
from the Aspergillus niger carbohydrase complex is used in this procedure. The
manufacturer conducted toxicological testing on the enzyme and determined that it
was safe to use in food preparation.
11 Inulin andGastrointestinal Disorders

250
The Joint FAO/WHO Expert Committee on Food Additives (JECFA2) believes
that using Aspergillus niger enzymes in food production poses no health risks to
humans. These enzymes are frequently employed in the food sector, such as in the
manufacturing of fruit juice.
The Aspergillus niger carbohydrase complex is protected in the United States by
an afrmation petition (GRASP 3G0016) that was led by the ad hoc Enzyme
Technical Committee in 1973 and is generally regarded as safe (GRAS). Inulinase’s
safety has been assessed by Danish authorities, who have approved its usage in the
synthesis of oligofructose. The French Council Superior d’Hygiene Public has also
assessed and suggested that the enzyme be allowed to be used in the synthesis of
several products, including oligofructose (Turner et al. 2013; United States Food
and Drug Administration 2018). Intestinal acceptability: Two key factors determine
whether nondigestible components are accepted in the stomach. The rst is the
osmotic action, which causes the colon’s water content to rise. Greater osmotic
pressure is exerted by smaller molecules, which causes the colon to absorb more
water. For example, sorbitol has a larger laxative potential than oligofructose, which
is likely due to this. The second is the fermentation effect, which is brought on
mostly by gasses and short-chain fatty acids that are byproducts of fermentation.
Compared to their fast-fermenting counterparts, substances that ferment slowly
seem to be more tolerable. This may help to explain why oligofructose is more dif-
cult to tolerate than inulin. Differentiating between a side effect of fermentation
that is acceptable and unacceptable might be challenging (Van Den Mooter
etal. 2003).
11.19.1 Tolerance
A soluble dietary ber known as inulin is fermented by colonic bacteria, is not
absorbed in the small intestine, and is resistant to hydrolysis by human digestive
enzymes. Prebiotic status for inulin is backed by research tracking its movement
through the digestive system. Prebiotics boost the bidobacterium, and feeding
experiments with oligofructose and inulin have demonstrated higher bidobacte-
rium counts. Additionally, inulin may be used as a fat substitute and is a simple
addition to popular meals like ice cream and chocolate bars (Mandracchia etal.
2015). Chocolate bars and other high-ber meals may contain chicory root extract—
a rich source of inulin—as the rst component on the ingredient label. Studies often
document atulence, bloating, distension, loose stools, and increased frequency of
stools as GI symptom. Comparing GI affects outcomes is challenging because there
are no recognized assessment measures for this purpose. Because of the osmotic
impact of increased water in the large intestine, inulin, like other dietary ber, can
produce discomfort. GI problems often worsen as inulin dosage increases and its
chain length shortens. Consuming inulin regularly may lead to an increase in GI
tolerance. It is anticipated that GI symptoms would worsen with doses of 15–30g
inulin; however, there are wide variations in research designs for tolerance trials
(Mandracchia et al. 2016, 2017). This study aimed to assess the gastrointestinal
S. K. Kadiri et al.

251
tolerance of two widely used inulin products administered to healthy participants at
two different dose levels: shorter-chain oligofructose and native inulin. We selected
5g of ber since the product label indicates that this is an excellent source of ber.
Since 10g of inulin and oligofructose can be readily added to high-ber bars and
other food products that are presently on the market, we decided to use this as our
upper dose. We predicted that both products, up to 10g, should be well tolerated and
not signicantly worsen gastrointestinal symptoms (Maris etal. 2001).
11.19.2 Potential Areas forFurther Exploration
andOpportunities forFurther Research
It has been claimed that inulin, a naturally occurring renewable polysaccharide
resource produced by a variety of plants in nature, has a wide range of unique phar-
macological and food applications. The development of high-throughput systems
and technologies for the assay of proteins, metabolites, mRNA, and gut microbiota
has accelerated recently. The inuence of inulin and inulin-containing prebiotics at
the transcriptome, proteome, metabolome, and gut microbiome levels is explained
as of right now using omics technology (Mauro etal. 2015a, b). Despite the fact that
inulin’s effects have been thoroughly studied, these omics technologies only allow
us to comprehend physiological information at each distinct level of mRNA, pro-
tein, metabolite, and gut microbe. However, a synergistic approach is necessary to
completely depict the intricate beauty hidden beneath the relatively little impact of
dietary variables such as inulin on host health.
11.19.3 Nutrigenomics intheStudy ofFood andNutrition
High-throughput platforms and technologies to evaluate global mRNA, proteins,
metabolites, and gut microbiota have advanced rapidly in recent years. As a result,
nutrigenomics—also known as nutriomics, which includes transcriptomics, pro-
teomics, metabolomics, and metagenomics—has been rapidly expanding, as
observed by today’s food and nutrition scientists. In the eld of “nutrigenomics,”
every bit of information that is now known about the genome and other biological
molecules is used to reveal every aspect of how diets and the human body interact
(Mensink etal. 2015a).
11.19.4 Transcriptome Analysis ofSupplemental Inulin
When compared to other omics technologies used in food research, transcriptomics
is the most commonly used one due to the many advantages of DNA microarray
technology, such as the comprehensiveness of gene expression data, established
protocols, and high data reliability and reproducibility. RNA-sequencing, some-
times referred to as whole-transcriptome sequencing, is another recently well-liked
11 Inulin andGastrointestinal Disorders

252
transcriptomics technique (Mensink et al. 2015b). A greater range of expression
values is captured by RNA-sequencing at adequate coverage as compared to micro-
arrays. Because it is a digital measure (count data), it scales linearly even at high
quantities, while analog-type uorescence signals only show saturation in microar-
rays. Additionally, RNA-sequencing offers details on RNA splice events, which are
difcult to nd with conventional microarrays (Merli etal. 2016).
11.19.5 Proteomic Analysis ofSupplemental Inulin
Proteome analyses typically entail the separation, quantication, and identication
of proteins. Proteins in biological samples are separated using two-dimensional gel
electrophoresis in conventional protein detection methods (Micka etal. 2017). The
isolated proteins are then visualized and quantied following silver or uorescent
staining. A more advanced technique based on the same separation concept is the
differential imaging gel electrophoresis method, in which proteins from various
samples are pre-labeled with various uorescent dyes. Two-dimensional chroma-
tography is typically used in chromatography for gel-free separation.
Before the rst freezing phase, proteins from chicory root were subjected to two-
dimensional electrophoretic analysis. Trypsin was used to digest the proteins, and
MS was used to examine the peptides. 714 proteins out of the 881 protein spots
examined matched a database accession; 619 of these proteins fell into the func-
tional groups of energy, protein synthesis, metabolism, cell structure, folding and
stability, proteolysis, and stress response. Since 7 of the 21 most intense protein
locations were found to be involved in cold acclimation, indicating the signicant
impact of the low-temperature interval preceding root harvesting, the signicance
of the abiotic stress response was conrmed (Moerman et al. 2004; Moore
etal. 2003).
11.20 Conclusion
In conclusion, this book offers a comprehensive investigation into the medicinal
potential of inulin to enhance gastrointestinal health. It claries the mechanisms via
which inulin improves disorders like IBS, IBD, and constipation by summarizing
recent research. Emphasizing its capacity to alter gut microbiota, encourage the
growth of benecial bacteria, and raise the production of short-chain fatty acids, the
book highlights how these modications enhance immune modulation, inamma-
tion reduction, and gut barrier integrity. It also tackles issues like the requirement
for customized treatments related to inulin supplementation and individual toler-
ance variations. The book also covers current studies being conducted to determine
the ideal inulin supplementation dosage, duration, and target population. All things
considered, it is a useful tool for researchers, consumers, and medical professionals
who want to use inulin to improve gastrointestinal health. In order to develop rm
recommendations for inulin supplementation and its incorporation into dietary
S. K. Kadiri et al.

253
guidelines for improved gastrointestinal health, it highlights the necessity for addi-
tional research.
References
Abad Alegria F, Gonzalez-Vivanco (2003) The health and nutritional virtues of artichokes-from
folklore to science. V International Congress on Artichoke 660, pp25–31
Abbasi AM, Khan MA, Ahmad M, Zafar M, Khan H, Muhammad N, Sultana S (2009) Medicinal
plants used for the treatment of jaundice and hepatitis based on socio-economic documenta-
tion. Afr J Biotechnol 8(8):1643–1650
Abed SM, Ali AH, Noman A, Niazi S, Ammar AF, Bakry AM (2016) Inulin as prebiotics and its
applications in food industry and human health; a review. Int J Agric Innov Res 5(1):88–97
Abou-Arab AA, Talaat H, Abu-Salem F (2011) Physicochemical properties of inulin produced
from Jerusalem artichoke tubers on bench and pilot plant scale. Aust J Basic Appl Sci
5(5):1297–1309
Abozed S, Abdelrashid A, El-Kalyoubi M, Hamad K (2009) Production of inulin and high-fruc-
tose syrup from Jerusalem artichoke tuber (Helianthus tuberosus L.). Ann Agric Sci (Cairo)
54(2):417–423
Anjuomo F, Abdella S, Youssef SH, Song Y, Garg S (2021) Inulin and its application in drug
delivery. Pharmaceuticals (Basel) 14(9):855. https://doi.org/10.3390/ph14090855. PMID:
34577554; PMCID: PMC8468356
Afzal S, Afzal N, Awan RM, Khan ST, Gilani A, Khanum R, Tariq S (2009) Ethno-botanical stud-
ies from northern Pakistan. J Ayub Med Coll Abbottabad 21(1):52–57
Ahmed N (2009) Alloxan diabetes-induced oxidative stress and impairment of oxidative
defense system in rat brain: neuroprotective effects of Cichorium intybus. Int J Diab Metab
17(3):105–109
Ahmed W, Rashid S (2019) Functional and therapeutic potential of inulin: A comprehensive
review. Crit Rev Food Sci Nutr 59(1):1–3
Akram W, Garud N, Joshi R (2019) Role of inulin as prebiotics on inammatory bowel disease.
Drug Discov Ther 13(1):1–8
Albers R, Antoine J-M, Bourdet-Sicard R, Calder PC, Gleeson M, Lesourd B et al (2005)
Markers to measure immunomodulation in human nutrition intervention studies. Br J Nutr
94(03):452–481
Alexiou H, Franck A (2008) Prebiotic inulin type fructans: nutritional benets beyond dietary bre
source. Nutr Bull 33(3):227–233
Alvarez PPF, Jurado BT, Calixto MC, Incio NV, Silva JA (2008) Prebiotic inulin/oligofructose in
Yacon root (Smallanthus sonchifolius), phytochemistry and standardization as basis for clinical
and pre-clinical research. Rev Gastroenterol Peru 28:22–27
Amorij JP, Saluja V, Petersen AH, Hinrichs WLJ, Huckriede A, Frijlink HW (2007a) Pulmonary
delivery of an inulin-stabilized inuenza subunit vaccine prepared by spray-freeze drying
induces systemic, mucosal humoral as well as cell-mediated immune responses in BALB/c
mice. Vaccine 25:8707–8717. https://doi.org/10.1016/j.vaccine.2007.10.035
Amorij JP, Meulenaar J, Hinrichs WLJ, Stegmann T, Huckriede A, Coenen F, Frijlink HW (2007b)
Rational design of an inuenza subunit vaccine powder with sugar glass technology: prevent-
ing conformational changes of haemagglutinin during freezing and freeze-drying. Vaccine
25:6447–6457. https://doi.org/10.1016/j.vaccine.2007.06.054
Anderson-Dekkers I, Nouwens-Roest M, Peters B, Vaughan E (2021) Inulin. In: Handbook of
hydrocolloids. Woodhead Publishing, pp537–562
Apolinario AC, de Lima Damasceno BPG, N. E. de Mac^edoBeltr~ao, A.Pessoa, A.Converti.
(2014) Inulin-type fructans: A review on different aspects of biochemical and pharmaceutical
technology. Carbohydr Polym 101:368–378
11 Inulin andGastrointestinal Disorders

254
Arango O, Trujillo AJ, Castillo M (2020) Inuence of fat substitution by inulin on fermentation
process and physical properties of set yoghurt evaluated by an optical sensor. Food Bioprod
Process 124:24–32
Aravind N, Sissons MJ, Fellows CM, Blazek J, Gilbert EP (2012) Effect of inulin soluble dietary
bre addition on technological, sensory, and structural properties of durum wheat spaghetti.
Food Chem 132(2):993–1002
Audouy SAL, van der Schaaf G, Hinrichs WLJ, Frijlink HW, Wilschut J, Huckriede A (2011)
Development of a dried inuenza whole inactivated virus vaccine for pulmonary immuniza-
tion. Vaccine 29:4345–4352. https://doi.org/10.1016/j.vaccine.2011.04.029
Azpiroz F, Molne L, Mendez S, Nieto A, Manichanh C, Mego M, Accarino A, Santos J, Sailer M,
Theis S, Guarner F (2017) Effect of chicory-derived inulin on abdominal sensations and bowel
motor function. J Clin Gastroenterol 51(7):619–625
Bakker-Zierikzee AM, Alles MS, Knol J, Kok FJ, Tolboom JJM, Bindels JG (2005) Effects of infant
formula containing a mixture of galacto- and fructo-oligosaccharides or viable Bidobacterium
animalis on the intestinal microora during the rst 4 months of life. Br J Nutr 94:783. https://
doi.org/10.1079/BJN20051451
Ballan R, Battistini C, Xavier-Santos D, Saad SM (2020) Interactions of probiotics and prebiotics
with the gut microbiota. Prog Mol Biol Transl Sci 171:265–300
Barber TM, Kabisch S, Pfeiffer AFH, Weickert MO (2020) The health benets of dietary bre.
Nutrients 12(10):3209. https://doi.org/10.3390/nu12103209. PMID: 33096647; PMCID:
PMC7589116
Bărboi OB, Ciortescu I, Chirilă I, Anton C, Drug V (2020) Effect of inulin in the treatment of
irritable bowel syndrome with constipation. Exp Ther Med 20(6):1
Bari H (2010) A prolonged release parenteral drug delivery system—an overview. Int J Pharm Sci
Rev Res 3:1–11
Beirão-da-costa ML, Isabel M, Januário N, Maria F, Simão S, Eduardo A, Leitão B.. Characterisation
of inulin from chicory and salsify cultivated in Portugal; 2005
Biruete A, Cross TW, Allen JM, Kistler BM, de Loor H, Evenepoel P, Fahey GC Jr, Bauer L,
Swanson KS, Wilund KR (2021) Effect of dietary inulin supplementation on the gut microbiota
composition and derived metabolites of individuals undergoing hemodialysis: a pilot study. J
Ren Nutr 31(5):512–522
Blecker C, Fougnies C, Van Herck JC, Chevalier JP, Paquot M (2002) Kinetic study of the acid
hydrolysis of various oligofructose samples. J Agric Food Chem 50:1602–1607. https://doi.
org/10.1021/jf010905b
Boeckner LS, Schnepf MI, & Tungland, BC (2001) Inulin: a review of nutritional and health
implications. Advances in food and nutrition research, 43:1–63. https://doi.org/10.1016/
s1043-4526(01)43002-6
Boets E, Deroover L, Houben E, Vermeulen K, Gomand SV, Delcour JA, Verbeke K (2015)
Quantication of in vivo colonic short chain fatty acid production from inulin. Nutrients
7(11):8916–8929
Bonnema AL, Kolberg LW, Thomas W, Slavin JL (2010a) Gastrointestinal tolerance of chicory
inulin products. J Am Diet Assoc 110(6):865–868
Bonnema AL, Kolberg LW, Thomas W, Slavin JL (2010b) Gastrointestinal tolerance of chicory
inulin products. J Am Diet Assoc 110:865–868. https://doi.org/10.1016/j.jada.2010.03.025
Bouchaud G, Castan L, Chesné J, Braza F, Aubert P, Neunlist M, Magnan A, Bodinier M (2016)
Maternal exposure to GOS/inulin mixture prevents food allergies and promotes tolerance in
offspring in mice. Allergy 71(1):68–76
Bouhnik Y, Raskine L, Champion K, Andrieux C, Penven S, Jacobs H, Simoneau G (2007)
Prolonged administration of low-dose inulin stimulates the growth of bidobacteria in humans.
Nutr Res 27(4):187–193
Brkljača J, Bodroža-Solarov M, Krulj J, Terzić S, Mikić A, Marjanović Jeromela A (2014)
Quantication of inulin content in selected accessions of Jerusalem artichoke (Helianthus
tuberosus L.). Helia 37:105–112. https://doi.org/10.1515/helia2014- 0009
S. K. Kadiri et al.

255
Bui TV, Prot-Bertoye C, Ayari H, Baron S, Blanchard A, Louet LL (2021) Safety of inulin and sini-
strin: combining several sources for pharmacovigilance purposes. Front Pharmacol 12:725417
Cammarota G, Ianiro G, Cianci R, Bibbò S, Gasbarrini A, Currò D (2015) The involvement of gut
microbiota in inammatory bowel disease pathogenesis: potential for therapy. Pharmacol Ther
149:191–212
Carabin IG, Flamm WG (1999) Evaluation of safety of inulin and oligofructose as dietary ber.
Regul Toxicol Pharmacol 30(3):268–282
Carlson JL, Erickson JM, Hess JM, Gould TJ, Slavin JL (2017) Prebiotic dietary ber and gut
health: comparing the invitro fermentations of beta-glucan, inulin and xylooligosaccharide.
Nutrients 9(12):1361
Carlson JL, Erickson JM, Lloyd BB, Slavin JL (2018) Health effects and sources of prebi-
otic dietary ber. Curr Dev Nutr 2(3):nzy005. https://doi.org/10.1093/cdn/nzy005. PMID:
30019028; PMCID: PMC6041804
Casellas F, Borruel N, Torrejon A, Varela E, Antolin M, Guarner F, Malagelada JR (2007) Oral
oligofructose-enriched inulin supplementation in acute ulcerative colitis is well tolerated and
associated with lowered faecal calprotectin. Aliment Pharmacol Ther 25(9):1061–1067
Causey JL, Feirtag JM, Gallaher DD, Tungland BC, Slavin JL (2000) Effects of dietary inulin on
serum lipids, blood glucose and the gastrointestinal environment in hypercholesterolemic men.
Nutr Res 20(2):191–201
Chambers ES, Byrne CS, Morrison DJ, Murphy KG, Preston T, Tedford C, Garcia-Perez I,
Fountana S, Serrano-Contreras JI, Holmes E, Reynolds CJ (2019) Dietary supplementation
with inulin-propionate ester or inulin improves insulin sensitivity in adults with overweight and
obesity with distinct effects on the gut microbiota, plasma metabolome and systemic inamma-
tory responses: a randomised cross-over trial. Gut 68(8):1430–1438
Crispín-Isidro G, Lobato-Calleros C, Espinosa-Andrews H, Alvarez-Ramirez J, Vernon-Carter EJ
(2015) Effect of inulin and agave fructans addition on the rheological, microstructural and sen-
sory properties of reduced-fat stirred yogurt. LWT Food Sci Technol 62(1):438–444
Dehghan P, Gargari BP, Asgharijafarabadi M (2013) Effects of high performance inulin supple-
mentation on glycemic status and lipid prole in women with type 2 diabetes: a randomized,
placebo-controlled clinical trial. Health Promot Perspect 3(1):55
Delzenne NM, Cani PD, Daubioul C, Neyrinck AM (2005) Impact of inulin and oligofructose on
gastrointestinal peptides. Br J Nutr 93(S1):S157–S161
Di Cairano M, Caruso MC, Galgano F, Favati F, Ekere N, Tchuenbou-Magaia F (2021) Effect of
sucrose replacement and resistant starch addition on textural properties of gluten-free doughs
and biscuits. Eur Food Res Technol 247(3):707–718
Dominguez AL, Rodrigues LR, Lima NM, Teixeira JA (2014) An overview of the recent devel-
opments on fructooligosaccharide production and applications. Food Bioprocess Technol
7:324–337
Drabińska N, Zieliński H, Krupa-Kozak U (2016) Technological benets of inulin-type fructans
application in gluten-free products–A review. Trends Food Sci Technol 56:149–157
Esmaeilnejad Moghadam B, Keivaninahr F, Fouladi M, Rezaei Mokarram R, Nazemi A (2019)
Inulin addition to yoghurt: prebiotic activity, health effects and sensory properties. Int J Dairy
Technol 72(2):183–198
Falony G, Lazidou K, Verschaeren A, Weckx S, Maes D, De Vuyst L (2009) In vitro kinetic analy-
sis of fermentation of prebiotic inulin-type fructans by Bidobacterium species reveals four
different phenotypes. Appl Environ Microbiol 75(2):454–461
Fatima I, Gamage I, De Almeida RJR, Cabandugama P, Kamath G (2023) Current understanding
of dietary ber and its role in chronic diseases. Mo Med 120(5):381–388. PMID: 37841565;
PMCID: PMC10569388
Fernandes R, do Rosario VA, Mocellin MC, Kuntz MG, Trindade EB (2017) Effects of inulin-type
fructans, galacto-oligosaccharides and related synbiotics on inammatory markers in adult
patients with overweight or obesity: a systematic review. Clin Nutr 36(5):1197–1206
Fu X, Liu Z, Zhu C, Mou H, Kong Q (2019) Nondigestible carbohydrates, butyrate, and butyrate-
producing bacteria. Crit Rev Food Sci Nutr 59(sup1):S130–S152
11 Inulin andGastrointestinal Disorders

256
Giri S, Dutta P, Giri TK (2021) Inulin-based carriers for colon drug targeting. J Drug Deliv Sci
Technol 64:102595
Guarner F (2005) Inulin and oligofructose: impact on intestinal diseases and disorders. Br J Nutr
93(S1):S61–S65
Guo L, Xiao P, Zhang X, Yang Y, Yang M, Wang T, Lu H, Tian H, Wang H, Liu J (2021) Inulin
ameliorates schizophrenia via modulation of the gut microbiota and anti-inammation in mice.
Food Funct 12(3):1156–1175
Guo J, Zhang M, Wang H, Li N, Lu Z, Li L, Hui S, Xu H (2022) Gut microbiota and short chain
fatty acids partially mediate the benecial effects of inulin on metabolic disorders in obese ob/
ob mice. J Food Biochem 46(5):e14063
Gupta N, Jangid AK, Pooja D, Kulhari H (2019) Inulin: A novel and stretchy polysaccharide tool
for biomedical and nutritional applications. Int J Biol Macromol 132:852–863
Harmsen HJ, Raangs GC, Franks AH, Wildeboer-Veloo AC, Welling GW (2002) The effect of the
prebiotic inulin and the probiotic Bidobacterium longum on the fecal microora of healthy
volunteers measured by FISH and DGGE.Microb Ecol Health Dis 14(4):212–220
Havenaar R, Bonnin-Marol S, Van Dokkum W, Petitet S, Schaafsma G (1999) Inulin: fermentation
and microbial ecology in the intestinal tract. Food Rev Intl 15(1):109–120
Healey G, Murphy R, Butts C, Brough L, Whelan K, Coad J (2018) Habitual dietary bre
intake inuences gut microbiota response to an inulin-type fructan prebiotic: a ran-
domised, double-blind, placebo-controlled, cross-over, human intervention study. Br J Nutr
119(2):176–189
Hiel S, Bindels LB, Pachikian BD, Kalala G, Broers V, Zamariola G, Chang BP, Kambashi B,
Rodriguez J, Cani PD, Neyrinck AM (2019a) Effects of a diet based on inulin-rich vegetables
on gut health and nutritional behavior in healthy humans. Am J Clin Nutr 109(6):1683–1695
Hiel S, Bindels LB, Pachikian BD, Kalala G, Broers V, Zamariola G, Chang BPI, Kambashi
B, Rodriguez J, Cani PD, Neyrinck AM, Thissen JP, Luminet O, Bindelle J, Delzenne NM
(2019b) Effects of a diet based on inulin-rich vegetables on gut health and nutritional behavior
in healthy humans. Am J Clin Nutr 109(6):1683–1695. https://doi.org/10.1093/ajcn/nqz001.
PMID: 31108510; PMCID: PMC6537941
Holownia P, Jaworska-Luczak B, Wisniewska I, Bilinski P, Wojtyla A (2010) The benets and
potential health hazards posed by the prebiotic inulin-a review. Polish J Food Nutr Sci 60(3)
Holscher HD, Doligale JL, Bauer LL, Gourineni V, Pelkman CL, Fahey GC, Swanson KS (2014)
Gastrointestinal tolerance and utilization of agave inulin by healthy adults. Food Funct
5(6):1142–1149
Hughes RL, Alvarado DA, Swanson KS, Holscher HD (2022) The prebiotic potential of inulin-
type fructans: a systematic review. Adv Nutr 13(2):492–529
Illippangama AU, Jayasena DD, Jo C, Mudannayake DC (2022) Inulin as a functional ingredient
and their applications in meat products. Carbohydr Polym 275:118706
Jackson PP, Wijeyesekera A, Rastall RA (2023) Inulin-type fructans and short-chain fructooligo-
saccharides—their role within the food industry as fat and sugar replacers and texture modi-
ers—what needs to be considered! Food Sci Nutr 11(1):17–38
Jenkins DJ, Kendall CW, Vuksan V (1999) Inulin, oligofructose and intestinal function. J Nutr
129(7):1431S–1433S
Kalyani Nair K, Kharb S, Thompkinson DK (2010) Inulin dietary ber with functional and health
attributes—A review. Food Rev Intl 26(2):189–203
Karimi R, Azizi MH, Ghasemlou M, Vaziri M (2015) Application of inulin in cheese as prebiotic,
fat replacer and texturizer: A review. Carbohydr Polym 119:85–100
Kaur N, Gupta AK (2002) Applications of inulin and oligofructose in health and nutrition. J Biosci
27:703–714
Kelly G (2008) Inulin-type prebiotics—a review: part 1. Altern Med Rev 13(4):315–329
Kolida S, Meyer D, Gibson GR (2007) A double-blind placebo-controlled study to establish the
bidogenic dose of inulin in healthy humans. Eur J Clin Nutr 61(10):1189–1195
Kruse HP, Kleessen B, Blaut M (1999) Effects of inulin on faecal bidobacteria in human subjects.
Br J Nutr 82(5):375–382
S. K. Kadiri et al.
Соседние файлы в папке Библиотека им академика М.И. Перельмана
